Published by Bloomberg Tax

A& Tax Managing Director Dan Peters was recently featured in Bloomberg Tax's article, 'Trump Pharma Pricing Order Piles on Transfer Pricing'. This article outlines President Donald Trump's executive order related to lowering US medicine prices and explores its implications for transfer pricing and existing tariff policies. 

"It’s the latest in a series of things causing pharmaceutical companies to reconsider all aspects of their international tax planning and their transfer pricing, and even further, how they organize their supply chain.”

Mr. Peters provides his perspective on the order, commenting on its anticipated effects on pharmaceutical company's international tax planning and supply chain organization.

Read The Full Article